As expected, we demonstrated that erianin triggered ferroptosis in lung cancer cells by activating Ca2+/CaM signaling, and the blockage of this signaling significantly decreased cell death caused by erianin treatment by suppressing ferroptosis (Fig. 9). The gene discussed is CALM1; the disease is lung carcinoma.